Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Yepes

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Circulation|August 7, 2002
Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic strokeZhenggang Zhang, Li Zhang, Manuel Yepes, et al.
The Journal of Clinical Investigation|June 19, 2002
Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independentManuel Yepes, Maria Sandkvist, Timothy A Coleman, et al.
BMC Research Notes|November 3, 2023
Simulation-based education in neurology: lessons from the COVID-19 pandemicJaime Toro, Juan Sebastián Rivera, Jairo Gaitán, et al.
Journal of Neuroinflammation|June 3, 2019
Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic strokeTianwen Gao, Syed Ali Raza, Supriya Ramesha, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 17, 2018
Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brainValerie Jeanneret, Juan P Ospina, Ariel Diaz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 26, 2020
Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic DamageAriel Diaz, Paola Merino, Ji-Dong Guo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 8, 2024
Plasminogen activator inhibitor-1 mediates cerebral ischemia-induced astrocytic reactivityPavel Yanev, Cynthia Martin-Jimenez, Diego Julian Vesga-Jimenez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 13, 2006
TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemiaXiaohui Zhang, Jeffrey A Winkles, Maria C Gongora, et al.
The Journal of Biological Chemistry|February 26, 2009
The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptorsHongjie Yuan, Katie M Vance, Candice E Junge, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 29, 2011
LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein traffickingSripriya Ranganathan, Nathaniel C Noyes, Mary Migliorini, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Circulation|August 7, 2002
Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic strokeZhenggang Zhang, Li Zhang, Manuel Yepes, et al.
The Journal of Clinical Investigation|June 19, 2002
Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independentManuel Yepes, Maria Sandkvist, Timothy A Coleman, et al.
BMC Research Notes|November 3, 2023
Simulation-based education in neurology: lessons from the COVID-19 pandemicJaime Toro, Juan Sebastián Rivera, Jairo Gaitán, et al.
Journal of Neuroinflammation|June 3, 2019
Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic strokeTianwen Gao, Syed Ali Raza, Supriya Ramesha, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 17, 2018
Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brainValerie Jeanneret, Juan P Ospina, Ariel Diaz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 26, 2020
Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic DamageAriel Diaz, Paola Merino, Ji-Dong Guo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 8, 2024
Plasminogen activator inhibitor-1 mediates cerebral ischemia-induced astrocytic reactivityPavel Yanev, Cynthia Martin-Jimenez, Diego Julian Vesga-Jimenez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 13, 2006
TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemiaXiaohui Zhang, Jeffrey A Winkles, Maria C Gongora, et al.
The Journal of Biological Chemistry|February 26, 2009
The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptorsHongjie Yuan, Katie M Vance, Candice E Junge, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 29, 2011
LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein traffickingSripriya Ranganathan, Nathaniel C Noyes, Mary Migliorini, et al.
Pageof 9